serum institute of india

NEW DELHI: India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's Covishield, from Friday.…

The Union health ministry has asked global vaccine alliance GAVI to supply 5 crore of the allocated 10 crore doses of Covishield to India under the COVAX facility free of cost, official sources said on Friday. Amid rising cases of…

NEW DELHI: The Union health ministry has asked global vaccine alliance GAVI to supply 5 crore of the allocated 10 crore doses of Covishieldto India under the COVAX facility free of cost, official sources said on Friday. Amid rising…

NEW DELHI: Serum Institute of India CEO Adar Poonawallaon Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year. The Drugs Controller General of India (DCGI) on…

The demand for Serum Institute of India's Covishield has gone down significantly from countries served by the Covax programme, according to a document on the World Health Organization-supported global Covid vaccine facility. These…

NEW DELHI: The government has allowed Serum Institute of India (SII) to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any…

NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said. The…

NEW DELHI: Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. The…

The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer, developed by the Serum Institute, official sources said on Sunday. A…

NEW DELHI: An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. The recommendation has been sent…